 |
|
What's New
|
Amex: ANX 0.295 -0.0102
|
January 04, 2010
ADVENTRX Pharmaceuticals Announces Financing
January 04, 2010
ADVENTRX Pharmaceuticals Submits ANX-530 New Drug Application
December 09, 2009
ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
December 1, 2009
ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
November 10, 2009
ADVENTRX Pharmaceuticals Reports Third Quarter Financial Results
October 22, 2009
ADVENTRX Pharmaceuticals to Present at the BIO Investor Forum on October 29
October 20, 2009
ADVENTRX Provides Business Update Following Recent Financing Activity
October 15, 2009
ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
October 09, 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
October 06, 2009
ADVENTRX Pharmaceuticals Announces Financing
September 14, 2009
ADVENTRX Intends Voluntary Withdrawal From NYSE Amex Upon Approval of NASDAQ Listing
August 12, 2009
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
August 10, 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
August 05, 2009
ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12
August 05, 2009
ADVENTRX Pharmaceuticals Announces Financing
August 04, 2009
ADVENTRX Narrows Prior Guidance on NDA Submission Timeline
August 03, 2009
ADVENTRX Announces Acceptance of Compliance Plan by NYSE AMEX
July 06, 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
June 29, 2009
ADVENTRX Pharmaceuticals Announces Plans for Remainder of 2009
June 29, 2009
ADVENTRX Pharmaceuticals Announces Financing
June 15, 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
June 8, 2009
ADVENTRX Pharmaceuticals Announces Financing
June 2, 2009
ADVENTRX Receives Notice From NYSE Amex
May 12, 2009
ADVENTRX Pharmaceuticals Reports First Quarter 2009 Financial Results
May 7, 2009
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
March 25, 2009
ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
March 25, 2009
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
|
